Evolving role of positron emission tomography in breast cancer imaging
- 30 April 2005
- journal article
- review article
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 35 (2), 84-99
- https://doi.org/10.1053/j.semnuclmed.2004.11.001
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Breast cancer models to study the expression of estrogen receptors with small animal PET imagingNuclear Medicine and Biology, 2004
- Impact on estrogen receptor binding and target tissue uptake of [18F]fluorine substitution at the 16α-position of fulvestrant (faslodex; ICI 182,780)Nuclear Medicine and Biology, 2004
- Staging in patients with locoregionally recurrent breast cancer: current practice and prospects for positron emission tomographyEuropean Journal Of Cancer, 2004
- Comparison of an 18F Labeled Derivative of Vasoactive Intestinal Peptide and 2-Deoxy-2-[18F]Fluoro-D-Glucose in Nude Mice Bearing Breast Cancer XenograftsMolecular Imaging & Biology, 2002
- Radiosynthesis of 3′-deoxy-3′-[18F]fluorothymidine: [18F]FLT for imaging of cellular proliferation in vivoNuclear Medicine and Biology, 2000
- Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistryEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Cancer Detection with Whole-Body PET Using 2-[18F]Fluoro-2-Deoxy-D-GlucoseJournal of Computer Assisted Tomography, 1993
- Haemodynamic and Transport Barriers to the Treatment of Solid TumoursInternational Journal of Radiation Biology, 1991
- Positron emission tomography imaging— Technical considerationsSeminars in Nuclear Medicine, 1986
- Predicting Response to Endocrine Therapy in Human Breast Cancer: A HypothesisScience, 1975